Magnetization transfer imaging in premanifest and manifest Huntington disease: A 2-year follow-up

American Journal of Neuroradiology

Volumn 34, Issue 2, 2013, Pages 317-322

  Van Den Bogaard, S J A ^a   Dumas, E M ^a   Hart, E P ^a   Milles, J ^a   Reilmann, R ^b   Stout, J C ^c   Craufurd, D ^d   Gibbard, C R ^e   Tabrizi, S J ^e   Van Buchem, M A ^a   Van Der Grond, J ^a   Roos, R A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; GLOBUS PALLIDUS; GRAY MATTER; HIPPOCAMPUS; HISTOGRAM; HUMAN; HUNTINGTON CHOREA; NUCLEAR MAGNETIC RESONANCE IMAGING; PUTAMEN; THALAMUS; WHITE MATTER;

ADULT; AMYGDALA; BASAL GANGLIA; BRAIN; CEREBRAL CORTEX; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HIPPOCAMPUS; HUMANS; HUNTINGTON DISEASE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; THALAMUS;

EID: 84876174747     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3303     Document Type: Article

References (34)

1. Dehmeshki J, Chard DT, Leary SM, et al. The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 2003;250:67-74 (Pubitemid 36206687)
2. Filippi M, Rocca MA. Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve. Neurotherapeutics 2007;4:401-13 (Pubitemid 46962400)
3. McGowan JC. The physical basis of magnetization transfer imaging. Neurology 1999;53(5 suppl 3):S3-7 (Pubitemid 29445034)
4. Ridha BH, Tozer DJ, Symms MR, et al. Quantitative magnetization transfer imaging in Alzheimer disease. Radiology 2007;244:832-37 (Pubitemid 47292095)
5. Eckert T, Sailer M, Kaufmann J, et al. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 2004;21:229-35 (Pubitemid 38115013)
6. van den Bogaard SJ, Dumas EM, Milles J, et al. Magnetization transfer imaging in premanifest and manifest Huntington disease. AJNR Am J Neuroradiol 2012;33:884-89
7. Ginestroni A, Battaglini M, Diciotti S, et al. Magnetization transfer MRimaging demonstrates degeneration of the subcortical and cortical gray matter in Huntington disease. AJNR Am J Neuroradiol 2010;31:1807-12
8. Anovel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes: the Huntington's Disease Collaborative Research Group. Cell 1993;72:971-83
9. Langbehn DR, Brinkman RR, Falush D, et al. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004;65:267-77 (Pubitemid 38443548)
10. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009;8:791-801
11. van den Bogaard SJ, Dumas EM, Acharya TP, et al. Early atrophy of pallidum and accumbens nucleus in Huntington's disease. J Neurol 2011;258:412-20
12. Dumas EM, van den Bogaard SJ, Ruber ME, et al. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Hum Brain Mapp 2012;33:203-12
13. Rosas HD, Tuch DS, Hevelone ND, et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. Mov Disord 2006;21:1317-25 (Pubitemid 44613279)
14. Rosas HD, Hevelone ND, Zaleta AK, et al. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005;65:745-47 (Pubitemid 41285856)
15. Henley SM, Frost C, Macmanus DG, et al. Increased rate of whole-brain atrophy over 6 months in early Huntington disease. Neurology 2006;67:694-96 (Pubitemid 44273624)
16. Mascalchi M, Lolli F, Della NR, et al. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 2004;232:867-73 (Pubitemid 39100275)
17. Jurgens CK, Bos R, Luyendijk J, et al. Magnetization transfer imaging in 'premanifest' Huntington's disease. J Neurol 2010;257:426-32
18. van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-54 (Pubitemid 29518136)
19. Filippi M, Rocca MA, Comi G. The use of quantitative magnetic-resonance- based techniques to monitor the evolution of multiple sclerosis. Lancet Neurol 2003;2:337-46 (Pubitemid 38352561)
20. Tabrizi SJ, Scahill RI, Durr A, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 2011;10:31-42
21. Penney JB Jr, Vonsattel JP, MacDonald ME, et al. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997;41:689-92 (Pubitemid 27212666)
22. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20:45-57 (Pubitemid 32293419)
23. Patenaude B, Smith SM, Kennedy DN, et al. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907-22
24. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208-19 (Pubitemid 39421720)
25. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479-89
26. Melzi L, Rocca MA, Marzoli SB, et al. A longitudinal conventional and magnetization transfer magnetic resonance imaging study of optic neuritis. Mult Scler 2007;13:265-68 (Pubitemid 46592784)
27. Mesaros S, Rocca M, Sormani M, et al. Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study. Mult Scler 2010;16:325-31
28. Filippi M, Inglese M, Rovaris M, et al. Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study. Neurology 2000;55:940-46
29. Emmer BJ, Steens SC, Steup-Beekman GM, et al. Detection of change in CNS involvement in neuropsychiatric SLE: a magnetization transfer study. J Magn Reson Imaging 2006;24:812-16 (Pubitemid 44546993)
30. Ge Y, Grossman RI, Babb JS, et al. Age-related total gray matter and white matter changes in normal adult brain. Part II. Quantitative magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol 2002;23:1334-41 (Pubitemid 35033882)
31. Tabrizi SJ, Reilmann R, Roos RA, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 2012;11:42-53
32. Paulsen JS, Magnotta VA, Mikos AE, et al. Brain structure in preclinical Huntington's disease. Biol Psychiatry 2006;59:57-63 (Pubitemid 43005236)
33. Zimbelman JL, Paulsen JS, Mikos A, et al. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J Int Neuropsychol Soc 2007;13:758-69 (Pubitemid 47299445)
34. Paulsen JS, Zimbelman JL, Hinton SC, et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. AJNR Am J Neuroradiol 2004;25:1715-21 (Pubitemid 44123696)